Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wadsworth

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Epigenetics|September 18, 2012
Novel target genes and a valid biomarker panel identified for cholangiocarcinomaKim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, et al.
Energy & Environmental Science|January 10, 2017
Reduced voltage losses yield 10% efficient fullerene free organic solar cells with >1 V open circuit voltagesD Baran, T Kirchartz, S Wheeler, et al.
Cell & Bioscience|April 17, 2024
Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal functionHillary A Wadsworth, Alicia M P Warnecke, Joshua C Barlow, et al.
Digestive Diseases (Basel, Switzerland)|June 22, 2011
Genetic factors in the pathogenesis of cholangiocarcinomaChristopher A Wadsworth, Peter H Dixon, Jason H Wong, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinaseS A Wadsworth, D E Cavender, S A Beers, et al.
Hepatology (Baltimore, Md.)|February 4, 2015
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinomaKim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, et al.
Addiction Biology|October 29, 2021
Modulation of dopamine release by ethanol is mediated by atypical GABA<sub>A</sub> receptors on cholinergic interneurons in the nucleus accumbensJordan T Yorgason, Hillary A Wadsworth, Elizabeth J Anderson, et al.
Journal of Clinical and Experimental Hepatology|April 27, 2019
Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for CholangiocarcinomaChristopher A Wadsworth, Peter H Dixon, Simon Taylor-Robinson, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Reactive oxygen species alter dopaminergic and purinergic signaling and microglia physiology in the nucleus accumbensH A Wadsworth, L H Ford, L R Hawley, et al.
Scientific Reports|October 29, 2021
Mapping of population disparities in the cholangiocarcinoma urinary metabolomeMunirah Alsaleh, Zoe Leftley, Thomas O'Connor, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Epigenetics|September 18, 2012
Novel target genes and a valid biomarker panel identified for cholangiocarcinomaKim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, et al.
Energy & Environmental Science|January 10, 2017
Reduced voltage losses yield 10% efficient fullerene free organic solar cells with >1 V open circuit voltagesD Baran, T Kirchartz, S Wheeler, et al.
Cell & Bioscience|April 17, 2024
Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal functionHillary A Wadsworth, Alicia M P Warnecke, Joshua C Barlow, et al.
Digestive Diseases (Basel, Switzerland)|June 22, 2011
Genetic factors in the pathogenesis of cholangiocarcinomaChristopher A Wadsworth, Peter H Dixon, Jason H Wong, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinaseS A Wadsworth, D E Cavender, S A Beers, et al.
Hepatology (Baltimore, Md.)|February 4, 2015
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinomaKim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, et al.
Addiction Biology|October 29, 2021
Modulation of dopamine release by ethanol is mediated by atypical GABA<sub>A</sub> receptors on cholinergic interneurons in the nucleus accumbensJordan T Yorgason, Hillary A Wadsworth, Elizabeth J Anderson, et al.
Journal of Clinical and Experimental Hepatology|April 27, 2019
Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for CholangiocarcinomaChristopher A Wadsworth, Peter H Dixon, Simon Taylor-Robinson, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Reactive oxygen species alter dopaminergic and purinergic signaling and microglia physiology in the nucleus accumbensH A Wadsworth, L H Ford, L R Hawley, et al.
Scientific Reports|October 29, 2021
Mapping of population disparities in the cholangiocarcinoma urinary metabolomeMunirah Alsaleh, Zoe Leftley, Thomas O'Connor, et al.
Pageof 10